• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Montelukast Teva 4 mg, 5 mg
    / Salomon, Levin & Elstein Ltd


    Active Ingredient
    Montelukast Sodium 4 mg, 5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Chewable Tablets

    28 x 4 mg

    partial basket chart 18620 13679

    Chewable Tablets

    28 X 5 mg

    partial basket chart 18625 13680

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    For pediatric patients 2-5 years of age (4 mg chewable tablets only), 6-14 years of age (5 mg chewable tablets only), and in adults and adolescents 15 years of age and older (10 mg tablets only) for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. Treatment is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. May be used concomitantly with inhaled corticosteroids with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.For the relief of symptoms of seasonal allergic rhinitis in pediatric patients 2-5 years of age (4 mg chewable tablets only), 6-14 years of age (5 mg chewable tablets only) and in adults and adolescents 15 years of age and older (10 mg tablets only).


    Contra-Indications

    Known hypersensitivity to the active ingredient or to any component of the product.


    Special Precautions

    Contact distributing company for full details.


    Side Effects

    Contact distributing company for full details.


    Drug interactions

    Contact distributing company for full details.


    Manufacturer
    Teva Operations, Poland
    CLOSE